Keyword | CPC | PCC | Volume | Score | Length of keyword |
---|---|---|---|---|---|
nivolumab opdivo | 0.21 | 0.6 | 60 | 91 | 16 |
nivolumab | 1.81 | 0.2 | 9767 | 65 | 9 |
opdivo | 0.86 | 1 | 9733 | 4 | 6 |
Keyword | CPC | PCC | Volume | Score |
---|---|---|---|---|
nivolumab opdivo | 1.27 | 0.4 | 4417 | 80 |
nivolumab opdivo + ipilimumab yervoy | 1.68 | 0.6 | 9077 | 49 |
nivolumab opdivo chemocare | 1.37 | 0.8 | 1513 | 90 |
nivolumab opdivo iv | 1.4 | 0.6 | 7891 | 56 |
nivolumab opdivo bristol myers squibb | 1.75 | 0.5 | 5253 | 60 |
nivolumab opdivo manufacturer | 0.46 | 0.4 | 2987 | 61 |
nivolumab opdivo side effects | 1.01 | 0.5 | 169 | 46 |
nivolumab opdivo and pembrolizumab keytruda | 0.57 | 0.1 | 6446 | 29 |
new lung cancer drug opdivo nivolumab | 1.76 | 0.7 | 5761 | 96 |
opdivo nivolumab price | 1.33 | 0.8 | 4567 | 56 |
opdivo nivolumab development history | 0.36 | 1 | 4203 | 24 |
opdivo nivolumab package insert | 1.62 | 1 | 1234 | 65 |